Bilateral adrenal myelolipoma in Cushing's disease: A relook into the role of corticotropin in adrenal tumourigenesis

8Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Adrenal myelolipomas are infrequently encountered benign tumours of unknown aetiology. In the majority of cases they are unilateral, and clinically and hormonally silent, only requiring periodic follow-up. However, bilateral adrenal myelolipomas are sometimes associated with endocrine disorders and warrant appropriate evaluation. Though the understanding of the pathophysiology of adrenal myelolipomas has long been elusive, adrenocorticotropic hormone (ACTH) has been proposed as the main tropic factor in a number of studies. Cushing's disease is rarely associated with bilateral and sometimes giant myelolipomas. In this article, the association of bilateral adrenal myelolipomas with Cushing's disease has been discussed and the role of ACTH in the tumourigenesis has been reviewed.

Cite

CITATION STYLE

APA

Chakraborty, P. P., Bhattacharjee, R., Mukhopadhyay, P., & Chowdhury, S. (2016). Bilateral adrenal myelolipoma in Cushing’s disease: A relook into the role of corticotropin in adrenal tumourigenesis. BMJ Case Reports, 2016. https://doi.org/10.1136/bcr-2016-214965

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free